ASH 2023 Lymphoma Recap with Toby Eyre, MD

By Blood Cancer Talks - Last Updated: March 20, 2024

In this episode of Blood Cancer Talks, Toby Eyre, MD, a consultant hematologist at the Oxford University Hospitals NHS Foundation Trust, joins hosts Raj Chakraborty, MD; Ashwin Kishtagari, MD; and Edward Cliff, MD; for a lymphoma recap from the 2023 American Society of Hematology (ASH) Annual Meeting & Exposition.

Dr. Eyre and the hosts highlighted abstracts in mantle cell lymphoma (MCL), including the BOVen trial of newly diagnosed transplant-eligible myeloma, and the SYMPATICO trial of ibrutinib plus venetoclax in relapsed or refractory MCL.

Subsequently, they highlighted abstracts in chronic lymphocytic leukemia, such as the FLAIR trial, as well as diffuse large B-cell lymphoma, including the Smart STOP study of lenalidomide, tafasitamab, rituximab, and acalabrutinib alone and with combination chemotherapy.

This podcast originally appeared on Blood Cancer Talks.

What are the Risk Factors, Treatment Options for Essential Thrombocythemia?

Dr. Samer Al Hadidi Discusses CAR-T MM Data Presented at the FDA ODAC Meeting

Ayalew Tefferi, MD, on Career Development as a Clinician-Investigator

Angela Dispenzieri, MD, on Managing Newly Diagnosed AL Amyloidosis

ASH 2023 Myeloid Recap With Anand Patel, MD

Editorial Board

Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine

Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center

Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center

Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University

Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center

Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch

Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer

ASH 2023 Lymphoma Recap with Toby Eyre, MD

Related